FDA Posts Questions and Answers About Increased Risks of Blood Clots With Birth Control Like Yaz and Yasmin

The FDA has posted questions and answers that provide a safety overview of Yaz and Yasmin. The link to the questions and answers is: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm273039.htm

The FDA provides answers to the following questions:

Q1. What is drospirenone?

Q2. Which birth control pills (oral contraceptives) contain drospirenone?

Q3. What is a venous thromboembolic event (VTE)?

Q4. What is already known about combination birth control pills and the risk of venous thromboembolism (VTE)?

Q5. How is FDA responding to new studies regarding the risk of venous thromboembolism (VTE) in women using birth control pills containing drospirenone?

Q6: What should healthcare professionals do when considering the use of birth control pills containing drospirenone?

Q7. What should women do if they are currently taking birth control pills containing drospirenone?

Q8. Are there women who should not take birth control pills, particularly those containing drospirenone?

Q9. Has FDA communicated to the public about this issue before?

If you are currently taking a birth control medication such as Yaz and Yasmin, we at the Levensten Law Firm urge you to go to the link to review the FDA answers to these important questions.

Leave a Reply

Your email address will not be published. Required fields are marked *